EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
September 30, 2026 2.641
June 30, 2026 2.677
March 31, 2026 2.243
December 31, 2025 2.250
September 30, 2025 2.106
June 30, 2025 2.210
March 31, 2025 2.210
December 31, 2024 2.101
September 30, 2024 2.105
June 30, 2024 1.748
March 31, 2024 1.641
December 31, 2023 1.505
September 30, 2023 1.517
June 30, 2023 1.545
March 31, 2023 1.268
December 31, 2022 1.100
September 30, 2022 2.558
June 30, 2022 1.174
March 31, 2022 0.6367
December 31, 2021 0.4214
September 30, 2021 0.4988
June 30, 2021 0.6226
March 31, 2021 0.5499
December 31, 2020 0.5508
September 30, 2020 0.3955
Date Value
June 30, 2020 0.3078
March 31, 2020 0.5162
December 31, 2019 0.7657
September 30, 2019 0.7528
June 30, 2019 0.6158
March 31, 2019 0.5001
December 31, 2018 0.5908
September 30, 2018 0.556
June 30, 2018 0.5382
March 31, 2018 0.2408
December 31, 2017 0.3684
September 30, 2017 0.23
June 30, 2017 0.36
March 31, 2017 0.30
December 31, 2016 0.20
September 30, 2016 0.37
June 30, 2016 0.38
March 31, 2016 0.15
December 31, 2015 0.23
September 30, 2015 0.28
June 30, 2015 0.32
March 31, 2015 0.23
December 31, 2014 0.22
September 30, 2014 0.29
June 30, 2014 0.26

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Globus Medical, Inc. 1.038
Abbott Laboratories 0.5294
AngioDynamics, Inc. -0.1689
Alphatec Holdings, Inc. -0.0348
AtriCure, Inc. 0.0816